WallStSmart

RTX Corporation (RTX)vsSBC Medical Group Holdings Incorporated (SBC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

RTX Corporation generates 53268% more annual revenue ($90.37B vs $169.34M). SBC leads profitability with a 24.1% profit margin vs 8.0%. SBC trades at a lower P/E of 7.5x. RTX earns a higher WallStSmart Score of 59/100 (C).

RTX

Buy

59

out of 100

Grade: C

Growth: 7.3Profit: 6.0Value: 4.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.58

SBC

Buy

52

out of 100

Grade: C-

Growth: 2.0Profit: 8.5Value: 6.7Quality: 8.5
Piotroski: 2/9Altman Z: 3.94

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RTX3 strengths · Avg: 8.7/10
Market CapQuality
$234.67B10/10

Mega-cap, among the largest globally

EPS GrowthGrowth
32.5%8/10

Earnings expanding 32.5% YoY

Free Cash FlowQuality
$1.21B8/10

Generating 1.2B in free cash flow

SBC6 strengths · Avg: 9.8/10
P/E RatioValuation
7.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
41.1%10/10

Strong operational efficiency at 41.1%

Debt/EquityHealth
0.0810/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.9410/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
24.1%9/10

Keeps 24 of every $100 in revenue as profit

Areas to Watch

RTX3 concerns · Avg: 4.0/10
PEG RatioValuation
2.404/10

Expensive relative to growth rate

P/E RatioValuation
32.7x4/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.584/10

Distress zone — elevated risk

SBC4 concerns · Avg: 2.5/10
Market CapQuality
$310.60M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-9.0%2/10

Revenue declined 9.0%

EPS GrowthGrowth
-47.1%2/10

Earnings declined 47.1%

Comparative Analysis Report

WallStSmart Research

Bull Case : RTX

The strongest argument for RTX centers on Market Cap, EPS Growth, Free Cash Flow.

Bull Case : SBC

The strongest argument for SBC centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 24.1% and operating margin at 41.1%.

Bear Case : RTX

The primary concerns for RTX are PEG Ratio, P/E Ratio, Altman Z-Score.

Bear Case : SBC

The primary concerns for SBC are Market Cap, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

RTX profiles as a value stock while SBC is a declining play — different risk/reward profiles.

SBC carries more volatility with a beta of 0.59 — expect wider price swings.

RTX is growing revenue faster at 8.7% — sustainability is the question.

RTX generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

RTX scores higher overall (59/100 vs 52/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

RTX Corporation

INDUSTRIALS · AEROSPACE & DEFENSE · USA

Raytheon Technologies Corporation is an American multinational aerospace and defense conglomerate headquartered in Waltham, Massachusetts. It is one of the largest aerospace, intelligence services providers, and defense manufacturers in the world by revenue and market capitalization. Raytheon Technologies (RTX) researches, develops, and manufactures advanced technology products in the aerospace and defense industry, including aircraft engines, avionics, aerostructures, cybersecurity, guided missiles, air defense systems, satellites, and drones.

Visit Website →

SBC Medical Group Holdings Incorporated

INDUSTRIALS · CONSULTING SERVICES · USA

SBC Medical Group Holdings, incorporated in Delaware in 2023 and headquartered in Tokyo, Japan, provides management services to cosmetic treatment centers primarily in Japan, with additional locations in Vietnam and California.

Visit Website →

Want to dig deeper into these stocks?